NMCIX
Price
$24.49
Change
+$0.04 (+0.16%)
Updated
Jul 31 closing price
Net Assets
754.6M
PAMCX
Price
$93.07
Change
-$0.30 (-0.32%)
Updated
Jul 31 closing price
Net Assets
22.11B
Interact to see
Advertisement

NMCIX vs PAMCX

NMCIX vs PAMCX Comparison Chart in %
View a ticker or compare two or three
VS
NMCIX vs. PAMCX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMCIX is a Hold and PAMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 22.1B vs. NMCIX (755M). NMCIX (0.00) and PAMCX (0.00) have matching dividends . NMCIX was incepted earlier than PAMCX: NMCIX (28 years) vs PAMCX (26 years). PAMCX (1.02) is less costly to investors than NMCIX (0.96). NMCIX is a more actively managed with annual turnover of: 87.00 vs. PAMCX (31.50). PAMCX has a lower initial minimum investment than NMCIX: PAMCX (2500) vs NMCIX (250000). PAMCX annual gain was more profitable for investors over the last year : -2.54 vs. NMCIX (-10.52). PAMCX (-23.44) and NMCIX (-24.27) have equivalent 5 years return.
NMCIXPAMCXNMCIX / PAMCX
Total Expense Ratio0.931.0291%
Annual Report Gross Expense Ratio0.961.0294%
Fund Existence28 years26 years-
Gain YTD6.0632.252269%
Front LoadN/AN/A-
Min. Initial Investment250000250010,000%
Min. Initial Investment IRAN/AN/A-
Net Assets755M22.1B3%
Annual Yield % from dividends0.000.00-
Returns for 1 year-10.52-2.54414%
Returns for 3 years4.79-5.35-90%
Returns for 5 years-24.27-23.44104%
Returns for 10 years-0.5324.04-2%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VNVYX21.090.11
+0.52%
Natixis Vaughan Nelson Mid Cap Y
UBPIX28.150.03
+0.11%
ProFunds UltraLatin America Inv
IVOIX18.84N/A
N/A
Nomura Mid Cap Income Opps I
SCSMX19.68-0.11
-0.56%
ClearBridge Small Cap Growth C
PREPX30.52-0.20
-0.65%
Principal Real Estate Securities R5